Pharmaceutical
Ex-GW Pharma Bosses Lead Development of New CBD-Based Epilepsy Drug
As reported by Cannabis Health Avata Biosciences is developing solid dose cannabinoid medicines for epilepsy and other neurological disorders, with a number of former GW Pharmaceutical bosses on board.